Original Article
Infectious Hepatitis
|
Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Hepatitis B: Protocol for a Phase 3 Randomized Trial
Xiaobo Cai, Yin Qu, Wen Xie, Yanbin Wang, Mengyu Zhao, Ling Zhang, Ying Luo, Ping Yin, Jun Cheng, Lungen Lu
Published online: March 10, 2025
J Clin Transl Hepatol. 2025;13(5):361-366. doi:10.14218/JCTH.2024.00472
|
Metabolic Liver Diseases
|
Analysis of the Disease Spectrum Characteristics of Inherited Metabolic Liver Diseases in Two Hepatology Specialist Hospitals in Beijing over the Past 20 Years
Wei Hou, Yuanzhi Huang, Tang Shang, Zheng Wang, Wei Zhang, Kefi Wang, Yinjie Gao, Min Zhang, Sujun Zheng
Published online: March 21, 2025
J Clin Transl Hepatol. 2025;13(5):367-373. doi:10.14218/JCTH.2025.00030
|
Hepatic and Biliary Neoplasia
|
GTF3C2 Promotes the Proliferation of Hepatocellular Carcinoma Cells through the USP21/MEK2/ERK1/2 Pathway
Yani Wu, Yingnan Yang, Youju Zhang, Qiuran Xu, Dongsheng Huang, Kangsheng Tu
Published online: February 11, 2025
J Clin Transl Hepatol. 2025;13(5):374-384. doi:10.14218/JCTH.2024.00386
|
|
FTO Promotes Hepatocellular Carcinoma Progression by Mediating m6A Modification of BUB1 and Targeting TGF-βR1 to Activate the TGF-β Signaling Pathway
Lin Zhang, Li Gan, Yuru Lin, Zhechuan Mei, Shengtao Liao
Published online: April 18, 2025
J Clin Transl Hepatol. 2025;13(5):385-394. doi:10.14218/JCTH.2025.00007
|
Liver Failure, Cirrhosis and Portal Hypertension
|
Mitochondrial Membrane Potential of CD8+ T Cells Predicts Bacterial Infection and Rapid Development of Acute-on-chronic Liver Failure in Cirrhotic Patients
Xixuan Wang, Shuling Chen, Jing Fan, Yuxiang Gong, Hongli Liu, Lili Wang, Xiaoning Feng, Hui Zhou, Wenquan Zeng, Changhua Yi, Caiyun Zhang, Qingfang Xiong, Hao Ren, Yongfeng Yang
Published online: February 25, 2025
J Clin Transl Hepatol. 2025;13(5):395-408. doi:10.14218/JCTH.2024.00452
|
Liver Injury, Autoimmune, and Cholestatic Diseases
|
Inhibition of Cyclooxygenase-2 Upregulates the Nuclear Factor Erythroid 2-related Factor 2 Signaling Pathway to Mitigate Hepatocyte Ferroptosis in Chronic Liver Injury
Zhu Yang, Yang Tai, Tian Lan, Chong Zhao, Jin-Hang Gao, Cheng-Wei Tang, Huan Tong
Published online: March 3, 2025
J Clin Transl Hepatol. 2025;13(5):409-417. doi:10.14218/JCTH.2024.00440
|
Review Article
|
Beyond the Cure: Navigating Hepatocellular Risk and Surveillance after Hepatitis C Eradication in the Direct-acting Antiviral Era
Chencheng Xie, Ashwani K. Singal
Published online: February 8, 2025
J Clin Transl Hepatol. 2025;13(5):418-424. doi:10.14218/JCTH.2024.00499
|
|
Non-variceal Extrahepatic Portosystemic Shunts: A Review of Pathogenesis, Diagnosis, and Treatment
Nicole M. Anastasio, George Y. Wu
Published online: March 14, 2025
J Clin Transl Hepatol. 2025;13(5):425-433. doi:10.14218/JCTH.2024.00315
|
Hot Topic Commentary
|
Key Points and Future Directions from the 2024 Chinese Guidelines for Fatty Liver Disease
Maria Tampaki, Evangelos Cholongitas
Published online: March 27, 2025
J Clin Transl Hepatol. 2025;13(5):434-439. doi:10.14218/JCTH.2025.00051
|
Corrigendum
|
Corrigendum: Ursolic Acid Modulates Estrogen Conversion to Relieve Inflammation in Metabolic Dysfunction-associated Steatotic Liver Disease via HSD17B14
Published online: April 28, 2025
J Clin Transl Hepatol. 2025;13(5):440-441. doi:10.14218/JCTH.2024.00414C
|